Current algorithms for the clinical management of patients with squamous cell carcinoma of
the head and neck (HNSCC) are based on a stage-dependent strategy where all patients at …

EGFR is an extensively studied biomarker in head and neck squamous cell carcinoma
(HNSCC). In this review, we discuss the prognostic and predictive role of EGFR in HNSCC …

Head and neck squamous cell carcinoma (HNSCC) is highly variable by tumor site,
histologic type, molecular characteristics, and clinical outcome. During recent years …

Laryngeal squamous cell carcinoma (LSCC), although one of the most common head and
neck cancers, has a static or slightly decreased survival rate because of difficulties in early …

The present study was undertaken to explore the association between the expression of
hepatocyte growth factor receptor (c‑Met) and epidermal growth factor receptor (EGFR) with …

The membrane EGFR (mEGFR) protein overexpression in the head and neck squamous cell
carcinoma (SCC) is considered to cause increased EGFR activity which adds to …

Background: Expression of the epidermal growth factor receptor (EGFR) and human
papillomavirus (HPV) DNA can serve as independent prognostic factors in squamous cell …

Vascular endothelial growth factor 2 (VEGFR2) was initially identified as a receptor of VEGF
on endothelial cells with a role in regulating angiogenesis during organism development …

Background/Aim: Epidermal growth factor receptor (EGFR) acts as an oncogene in
malignancies. Our aim was to examine the role of combined EGFR/anaplastic lymphoma …

Background: Various molecular biomarkers, including epidermal growth factor receptor
(EGFR), have gained importance as predictors of head and neck cancer disease …